President’s Research Fund (PRF)
The President’s Research Fund (PRF) supports projects that have a strong potential for obtaining external funding for SLU investigators. The funds are used to collect preliminary data for a new or related project, and also support cross-disciplinary projects to maximize collaborations across departments and schools at SLU.
Awards of up to $50,000 will be awarded, with a total amount of $125,000 allocated to the PRF in the School of Medicine for each cycle. Applications are accepted twice a year, in May and October, and are for a period of one calendar year. Information on changes to the funding deadlines and amounts can be viewed here: PRF Email.
For the Spring 2015 cycle, only full-time, tenure and non-tenure track faculty members in the School of Medicine may submit an application as PI or Co-PI. One application per deadline may be submitted. In accordance with the recent federal award policy change, previously unfunded PRF applications may be resubmitted an unlimited number of times.
To learn about the criteria used to evaluate internal proposals, please review our Internal Awards Peer Review Form.
- Two Annual Deadlines: October 31 and May 15
- Spring 2015 forms: PRF Guidelines, Application Package, and Subrecipient Form.
- The deadline for the Fall 2015 application cycle will be announced soon.
- Applications must be submitted through eRS.
- Questions? Contact Emily Beck in the Office of Research Development & Services (ORDS) at 977-7742 or via Email.
Award recipients for the Spring 2015 application cycle are listed below. Each awardee received $25.000 in funds.
|Thomas Cho, Ph.D.||Biochemistry & Molecular Biology||“The role of MIF-bacterial endotoxin interactions in sepsis: A potential cause of septic shock”|
|Reigh-Yi Lin, Ph.D.||Internal Medicine-Otolaryngology||“The role of receptor for advanced glycation endproducts in anaplastic thyroid cancer”|
|Sarah Howe McBride-Gagyi, Ph.D.||Orthopaedic Surgery||“The effects of spacer material and topography on bone formation using the induced membrane technique”|
|Lynda Morrison, Ph.D.||Molecular Microbiology and Immunology||“ADME and PK studies with novel herpesvirus inhibitors from two chemical classes”|
|Ryan M. Teague, Ph.D.||Molecular Microbiology and Immunology||“Exploring immunotherapy and oncolytic adenovirus as a novel combination therapy for cancer”|